Adult blood lead epidemiology and surveillance - United States, fourth quarter, 1995.
During October-december 1995, the 6553 reports of BLLs [less than or equal to] 25 [mu]g/dl represented a 4% decrease from the 6821 reports for the fourth quarter of 1994, which now include previously unpublished data for Maine (2). Compared with the fourth quarter of 1994, reports for the same period of 1995 increased 1% at the 25-39 [mu]g/dl level; reports decreased 15% at the 40-49 [mu]g/dl level, 27% at the 50-59 [mu]g/dl level, and 10% at the >60 lig/dl level. For 1995, cumulative reports of BLLS [less than or equal to] 25 [mu]g/dl decreased 10% from reports for 1994 (Table 1). The cumulative number of reports decreased at each reporting level.
[TABULAR DATA 1 OMITTED]
Compared with 1994, the increase in the number of reports at the highest reporting level ([less than or equal to] 60 [mu]g/dl) in the second and third quarters of 1995 (3) did not continue into the fourth quarter; the number of BLL reports during the fourth quarter in this category declined from 114 to 102 (2). The percentage of all reported BLLS at the [less than or equal to] 60 [mu]g/dl level was 3% in 1992 (4) and remained at 2% in 1993 (2),1994 (5) and 1995 (Table 1).
Reported by. JP Lofgren, MD, Alabama Dept of Public Health. C Fowler, MS, Arizona Dept of Health Svcs. S Payne, MA, Occupational Lead Poisoning Prevention Program, Califomia Dept of Health Svcs. BC Jung, MPH, Connecticut Dept of Public Health. M Lehnherr, Occupational Disease Registry, Div of Epidemiologic Studies, Illinois Dept of Public Health. R Gergely, lowa Dept of Public Health. A Hawkes, MD, Occupational Health Program, Maine Bur of Health. E Keyvan-larijani, MD, Lead Poisoning Prevention Program, Maryland Dept of the Environment. R Rabin, MSPH, Div of Occupational Hygiene, Massachusetts Dept of Labor and industries. M Scoblic, MN, Michigan Dept of Public Health. L Thistle-elliott, Med, Div of Public Health Svcs, New Hampshire State Dept of Health and Human Svcs. B Gerwel, MD, Occupational Disease Prevention Project, New Jersey State Dept of Health. R Stone, Phd, New York State Dept of Heaith. S Randolph, MSN, North Carolina Dept of Environment, Health, and Natural Resources. E Rhoades, MD, Oklahoma State Dept of Health. A Sandoval, MS, State Health Div Oregon Dept of Human Resources. J Gostin, MS, Occupational Health Program, Div of Environmental Health, Pennsylvania Dept of Health. R Marino, MD, Div of Health Hazard Evaluations, South Carolina Dept of Health and Environmental Control P Schnitzer Phd, Bur of Epidemiology, Texas Dept of Health. W Ball, Phd, Bur of Epidemiology, Utah Dept of Health. L Toof Div of Epidemiology and Health Promotion, Vermont Dept of Health. J Kaufman, MD, Washington State Dept of Labor and industries. V Ingram-stewart, MPH, Wisconsin Dept of Health and Social Svcs. Div of Surveillance, Hazard Evaluations, and Field Studies, National Institute for Occupational Safety and Health, CDC.
Editorial Note: Variation in national quarterly reporting totals may result from 1) changes in the number of participating states, 2) timing of receipt of laboratory BLL reports by state-based surveillance programs, 3) changes in staffing and funding of state-based surveillance programs, and 4) interstate differences in worker BLL testing by lead-using industries. Variation from these sources reduces the capability to confidently identify trends in the actual data reported.
The findings in this report document the continuing hazard of work-related lead exposures as an occupational health problem in the United States. ABLES enhances surveillance for this preventable condition by expanding the number of participating states, reducing variability in reporting, and distinguishing between new and recurring elevated BLLS among adults.
(1.) CDC. Surveillance of elevated blood lead levels among adults--United States, 1992. MMWR 1992;41:285-8. (2.) CDC. Adult Blood Lead Epidemiology and Surveillance--United States, fourth quarter, 1994. MMWR 1995;44:286-7. (3.) CDC. Adult Blood Lead Epidemiology and Surveillance--United States, third quarter, 1995. MMWR 1996;45:170-1. (4.) CDC. Adult Blood Lead Epidemiology and Surveillance-United States, fourth quarter, 1992. MMWR 1993;42:254. (5.) CDC. Adult Blood Lead Epidemiology and Surveillance--United States, 1994 and first quarter, 1995. MMWR 1995;44:515-7.
|Printer friendly Cite/link Email Feedback|
|Publication:||Morbidity and Mortality Weekly Report|
|Date:||Apr 26, 1996|
|Previous Article:||Multidrug-resistant tuberculosis outbreak on an HIV ward - Madrid, Spain, 1991-1995.|
|Next Article:||National Melanoma/Skin Cancer Detection and Prevention Month, May 1996.|